Topical Low Dose Preservative-Free Hydrocortisone Reduces Signs and Symptoms in Patients with Chronic Dry Eye: A Randomized Clinical Trial

ConclusionTreatment with low dose hydrocortisone 0.335% reduced ocular inflammation and decreased OSDI score. No change in IOP was observed in either of the two treatment schedules. Because of its good safety profile, low dose hydrocortisone may be an interesting alternative to standard corticosteroid treatment in DED.FundingLaboratories Thea.Trial RegistrationClinicaltrials.gov registry: NCT03907865.
Source: Advances in Therapy - Category: Drugs & Pharmacology Source Type: research